The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry. Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more. At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution. Links: Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Ep. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem The chronic condition we should be talking about: Challenges and opportunities in migraine care Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.